issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid. Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act. Issues related to the launch of AbbVie's Hepatitis C Drug.
Corporate tax reform in general.
Issues related to coverage and reimbursement pharmaceuticals.
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Duration: February 1, 2013
to
April 30, 2015
General Issues: Health Issues , Taxation/Internal Revenue Code , Pharmacy , Medical/Disease Research/Clinical Labs , Medicare/Medicaid , Copyright/Patent/Trademark , Trade (Domestic & Foreign)
Spending: about $0 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2013: U.S. Senate, U.S. Senate,, House of Representatives
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Bryant Hall Legislative Correspondent, Senator Bob Graham
Legislative Assistant, Senator Bob Graham
Health Care Counsel, Senator Bob Graham
Legislative Director, Senator Bob Graham
Staff Director, Senate Comm. on Veterans Affairs
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2015
Tiber Creek Health Strategies, Inc. terminated an engagement in which they represented Peck Madigan Jones (On behalf of AbbVie Inc.) on July 20, 2015.
Original Filing: 300746966.xml
1st Quarter, 2015
In Q1, Tiber Creek Health Strategies, Inc. lobbied for Peck Madigan Jones (On behalf of AbbVie Inc.) . The report was filed on April 20, 2015.
Original Filing: 300727172.xml
Lobbying Issues
issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid. Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act. Issues related to the launch of AbbVie's Hepatitis C Drug.
Lobbying Issues
Corporate tax reform in general.
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to coverage and reimbursement pharmaceuticals.
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Type of Issue
Medical/Disease Research/Clinical Labs/Medicaid
4th Quarter, 2014
In Q4, Tiber Creek Health Strategies, Inc. lobbied for Peck Madigan Jones (On behalf of AbbVie Inc.) . The report was filed on Jan. 20, 2015.
Original Filing: 300706842.xml
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid. Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act.
Lobbying Issues
Corporate tax reform in general.
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals.
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2014
In Q3, Tiber Creek Health Strategies, Inc. lobbied for Peck Madigan Jones (On behalf of AbbVie Inc.) . The report was filed on Oct. 20, 2014.
Original Filing: 300687926.xml
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid. Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act.
Lobbying Issues
Corporate tax reform in general.
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals.
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2014
In Q2, Tiber Creek Health Strategies, Inc. lobbied for Peck Madigan Jones (On behalf of AbbVie Inc.) . The report was filed on July 21, 2014.
Original Filing: 300668931.xml
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid. Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act.
Lobbying Issues
Corporate tax reform in general.
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs/Medicaid
1st Quarter, 2014
In Q1, Tiber Creek Health Strategies, Inc. lobbied for Peck Madigan Jones (On behalf of AbbVie Inc.) . The report was filed on April 21, 2014.
Original Filing: 300646033.xml
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid. Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act.
Lobbying Issues
Corporate tax reform in general.
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs/Medicaid
4th Quarter, 2013
In Q4, Tiber Creek Health Strategies, Inc. lobbied for Peck Madigan Jones (On behalf of AbbVie Inc.) . The report was filed on Jan. 21, 2014.
Original Filing: 300623264.xml
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid. Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Corporate tax reform in general.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Track and trace drug verification. H.R. 3204, Drug Quality and Security Act.
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs/Medicaid
3rd Quarter, 2013
In Q3, Tiber Creek Health Strategies, Inc. lobbied for Peck Madigan Jones (On behalf of AbbVie Inc.) . The report was filed on Oct. 21, 2013.
Original Filing: 300606619.xml
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid. Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to potential tax legislation.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Track and trace drug verification. H.R. 3204, Drug Quality and Security Act.
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs/Medicaid
2nd Quarter, 2013
In Q2, Tiber Creek Health Strategies, Inc. lobbied for Peck Madigan Jones (On behalf of AbbVie Inc.) . The report was filed on July 22, 2013.
Original Filing: 300585720.xml
Lobbying Issues
Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to potential tax legislation.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Track and trace drug verification.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, Tiber Creek Health Strategies, Inc. lobbied for Peck Madigan Jones (On behalf of AbbVie Inc.) . The report was filed on April 22, 2013.
Original Filing: 300563827.xml
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Disease Research/Clinical Labs/Medicaid
Lobbying Issues
Corporate tax reform in general.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to the Trans-Pacific Partnership. Data exclusivity and intellectual property.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Issues related to coverage and reimbursement of pharmaceuticals.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
Tiber Creek Health Strategies, Inc. filed a lobbying registration on March 13, 2013 to represent Peck Madigan Jones (On behalf of AbbVie Inc.), effective Feb. 1, 2013.
Original Filing: 300546377.xml
Issue(s) they said they’d lobby about: Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation. Corporate tax reform in general. Issues related to the Trans-Pacific Partnership. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...